#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Still's disease Pulmonary sarcoidosis Erdheim-Chester disease Thalassaemia alpha Canavan disease Systemic mastocytosis Central nervous system neoplasm Anal cancer Henoch-Schonlein purpura Diabetes insipidus Gastrointestinal stromal tumour Extranodal marginal zone B-cell lymphoma (MALT type) Congenital leptin deficiency Bulbospinal muscular atrophy congenital Acute myeloid leukaemia recurrent More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Trials in Disease Chondrosarcoma metastatic – Trials in Disease Medulloblastoma recurrent – Basic Information Sarcoma – Diagnostics Haemophilia A without inhibitors – Treatment Wiskott-Aldrich syndrome – Treatment Malignant fibrous histiocytoma – Treatment Angiosarcoma recurrent – Trials in Disease Bronchiolitis obliterans syndrome – Diagnostics Glomerulonephritis rapidly progressive More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Nitroprusside Dihydrate Sodium 2-Hydroxylinoleate Temozolomide Tilmanocept Pomalidomide Clofutriben Valbenazine Ditosylate Azd8421 Amivantamab Pegunigalsidase Alfa Methylphenidate Hydrochloride E.coli Polysaccharide Thiotepa ZIMISLECEL Islatravir Elasomeran Transpocart19 Gs-4182 Artemisia Vulgaris (312) Hypothalamic Phospholipids More therapies…

    Learn about Your Condition

    Cardiac failure congestive Malignant glioma Joint stabilisation Notalgia paraesthetica Labour pain Postoperative wound infection Antithrombin III deficiency Adenomatous polyposis coli Ataxia telangiectasia Arrhythmia supraventricular Prodromal Alzheimer's disease Adrenocortical carcinoma Leiomyosarcoma metastatic Lymphatic malformation Acquired haemophilia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Testing bifikafusp alfa and onfekafusp alfa injections in patients with locally advanced basal cell carcinoma

    Recruiting

    2 1 1
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    Germany Greece Italy Spain

  • A Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is

    Recruiting

    2 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Zasocitinib
    France Italy Poland Spain

  • A Study of Anifrolumab for Patients with Cutaneous Lupus Erythematosus to Measure Changes in Skin and Blood Inflammation and Clinical Outcomes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cutaneous lupus erythematosus
    Investigated Drugs:
    • Anifrolumab
    Austria

  • A Study of BCX17725 Safety and Effects in Healthy People and Patients with Netherton Syndrome

    Recruiting

    1 1 1
    France Germany The Netherlands

  • Testing two moisturizing creams with urea, propylene glycol, and propylene glycol alone for preventing flare-ups in patients with atopic dermatitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Propylene Glycol
    • Urea
    Norway Sweden

  • Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lenalidomide
    • Methotrexate
    France
Previous Page
1 2 3 4 5 6 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!